Skip to content
Search

Latest Stories

Whooping cough outbreak in England: 9 infant deaths in six months

Whooping cough outbreak in England: 9 infant deaths in six months

A combination of factors, including a decline in vaccination uptake, is believed to be contributing to the rise in the cases.

Whooping Cough Outbreak

A total of 7,599 whooping cough cases have been recorded in England from January to May 2024, according to new data released by the UK Health Security Agency (UKHSA).


In January 2024, there were 555 cases, followed by 920 in February, 1,427 in March, 2,106 in April, and 2,591 in May.

While the majority of cases (over 53 per cent) occurred in individuals aged 15 years or older, who typically experience milder symptoms, a significant number (262) were reported in babies under 3 months old, who are at the highest risk of severe complications and death from whooping cough.

Since the outbreak began in November last year, there have been nine infant deaths (one in December 2023 and eight between January and May 2024).

Whooping cough, or pertussis, is a bacterial infection affecting the lungs. This cyclical disease peaks every 3 to 5 years, with the last increase seen in 2016.

A combination of factors, including a decline in vaccination uptake, is believed to be contributing to the rise in whooping cough cases.

The latest UKSHA data showed a continued decline in uptake for the vaccination offered to pregnant women to protect newborns against whooping cough, with coverage in March 2024 at 58.9 per cent, down from its peak of 72.6 per cent in March 2017.

“Vaccination is the best defence against whooping cough,” said Dr Mary Ramsay, Director of Immunisation at UK Health Security Agency, stressing the importance of timely vaccination during pregnancy and in childhood.

Pregnant women are offered a whooping cough vaccine during each pregnancy, ideally between 20 and 32 weeks.

According to Dr Ramsay, pregnant women are offered a whooping cough vaccine in every pregnancy, ideally between 20 and 32 weeks.

“This passes protection to their baby in the womb so that they are protected from birth in the first months of their life when they are most vulnerable and before they can receive their own vaccines,” Dr Ramsay said.

Timely vaccination during pregnancy has proven to provide 92 percent protection against infant death.

All babies are given three doses of the 6-in-1 jab at 8, 12 and 16 weeks of age to protect against whooping cough and other serious diseases such as diphtheria and polio, with a pre-school booster offered at 3 years 4 months.

“With cases continuing to rise and sadly 9 infant deaths since the outbreak began last November, ensuring women are vaccinated appropriately in pregnancy has never been more important,” Dr Ramsay noted.

Kate Brintworth, Chief Midwifery Officer for England, said the NHS is identifying areas at greater risk and implementing robust local vaccination programmes.

She urged pregnant women to get vaccinated to help protect their babies, citing Women can access the vaccine, which also protects against diphtheria and tetanus, through their GP or some antenatal services.

She has urged pregnant women to get vaccinated to help protect their babies, noting that women can access the vaccine, which also protects against diphtheria and tetanus, through their GP or some antenatal services.

“Parents should also ensure that their children get protected in the first few months after birth as part of the routine NHS vaccine offer,” Brintworth added.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less